GHK-Cu and Epithalon address two distinct layers of the aging process. GHK-Cu has one of the largest in vitro evidence bases in skin and collagen research. Epithalon has been studied for telomere elongation and longevity at the cellular level. This page covers what the research actually shows for each compound and what they cost per milligram.
GHK-Cu and Epithalon appear frequently in the same longevity and anti-aging research discussions because they are proposed to address different biological mechanisms involved in aging. GHK-Cu (glycyl-L-histidyl-L-lysine-copper) is a copper-binding peptide that occurs naturally in human plasma; serum levels decline significantly between age 20 and 60. Research interest centers on its effects on collagen synthesis, skin remodeling, and gene expression patterns associated with aging in the extracellular matrix.
Epithalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide derived from the pineal gland extract Epithalamin. Research interest centers on telomere length and telomerase activity: the cellular aging clock that operates independently of the extracellular environment. The two compounds are studied at different biological scales. GHK-Cu research focuses on tissue-level and matrix-level changes; Epithalon research focuses on intracellular and chromosomal mechanisms. This is the basis for the pairing in anti-aging research protocols.
| Property | GHK-Cu | Epithalon |
|---|---|---|
| Biological target | Extracellular matrix, collagen synthesis, fibroblast activation, gene expression | Telomere length, telomerase enzyme activity, pineal gland function, melatonin regulation |
| Primary research model | Human fibroblast cultures (in vitro); some cosmetic human studies for topical forms | Human cell lines (in vitro) and rodent lifespan studies (animal models) |
| Natural occurrence | Occurs naturally in human plasma; levels decline from ~200 ng/ml at age 20 to ~80 ng/ml by age 60 | Synthetic analog of a sequence found in bovine pineal extract; does not occur in this exact form naturally |
| Administration studied | Topical (cosmetics research), subcutaneous injection, intranasal | Subcutaneous injection (animal studies), intranasal (neurological research) |
| Human clinical data | Limited: cosmetic formulations have been tested; no human RCTs for systemic use | None published as of 2026; evidence base is preclinical |
The evidence for GHK-Cu is stronger than for most research peptides at the mechanistic level: the collagen synthesis findings in fibroblast cultures have been replicated across multiple laboratories, and the compound has decades of cosmetic research behind it. The gap is at the clinical level: there are no human RCTs for systemic injectable GHK-Cu, and the evidence for cosmetic topical forms is not directly transferable to injectable research protocols.
Epithalon's evidence base is more concentrated. Most of the published animal work comes from a single Russian research group, which limits independent replication for the lifespan findings. The telomere elongation mechanism has now been replicated in vitro by an independent group (2025), which strengthens the cellular mechanism argument. The absence of any human clinical data for either compound means researchers are working with mechanistic hypotheses, not confirmed human outcomes.
GHK-Cu is typically sold in larger vials than Epithalon because it is used at higher per-application amounts in cosmetic research. Epithalon vials tend to be smaller. The per-mg prices below reflect typical vendor pricing as of 2025.
| Compound | Typical vial sizes | Price range (per vial) | Price per mg |
|---|---|---|---|
| GHK-Cu | 50 mg, 100 mg | $150–$800 | $3–$8 |
| Epithalon | 10 mg, 20 mg | $20–$120 | $2–$6 |